Loading...

StateHouse Holdings Inc.

STHZ.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$0.00(0.00%)
Canadian Market opens in 7h 23m

StateHouse Holdings Inc. (STHZ.CN) Stock Competitors & Peer Comparison

See (STHZ.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
STHZ.CNCA$0.03+0.00%7.7M-0.10-CA$0.31N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$8.09+1.51%3B13.95CA$0.58N/A
CURA.TOCA$3.74+4.18%2.9B-8.50-CA$0.44N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$9.22-0.97%2.2B14.09CA$0.66N/A
TRUL.CNCA$8.72-2.57%1.5B-10.90-CA$0.80N/A
CRON.TOCA$3.70+0.54%1.4B-123.33-CA$0.03N/A
TLRY.TOCA$9.45+0.96%1.1B-0.47-CA$20.27N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

STHZ.CN vs CURA.CN Comparison April 2026

STHZ.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STHZ.CN stands at 7.7M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, STHZ.CN is priced at CA$0.03, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STHZ.CN currently has a P/E ratio of -0.10, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, STHZ.CN's ROE is +0.36%, compared to CURA.CN's ROE of -0.24%. Regarding short-term risk, STHZ.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for STHZ.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions